MACE according to combinations of overlapping stents
| Homogeneous DES | Number | MACE | Heterogeneous DES | Number | MACE |
| SES+SES | 410 (43.6) | 39 (41.5) | SES+PES | 52 (37.1) | 7 (43.8) |
| PES+PES | 198 (21.1) | 33 (35.1) | SES+ZES | 18 (12.9) | 1 (6.3) |
| ZES+ZES | 117 (12.4) | 8 (8.5) | PES+ZES | 15 (10.7) | 1 (6.3) |
| EES+EES | 197 (21.0) | 14 (14.9) | SES+EES | 18 (12.9) | 2 (12.5) |
| Others | 18 (1.9) | 0 (0) | PES+EES | 17 (12.1) | 3 (18.8) |
| ZES+EES | 17 (12.1) | 2 (12.5) | |||
| Other | 3 (2.1) | 0 (0) | |||
| 940 (100) | 94 (100) | 140 (100) | 16 (100) |
Variables presented as number (%).
DES, drug-eluting stent; EES, everolimus-eluting stent; MACE, major adverse cardiac events; PES, paclitaxel-eluting stent; SES, sirolimus-eluting stent; ZES, zotarolimus-eluting stent.